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Abstract
We previously reported that overexpression of HSP25 delayed
cell growth, increased the level of p21waf, reduced the levels of
cyclin D1, cyclin A and cdc2, and induced radioresistance in
L929cells. In this study,wedemonstrated thatHSP25 induced-
radioresistance was abolished by transfection with plasmids
containing antisense hsp25 cDNA. Extracellular regulated
kinase (ERK) and MAP kinase/ERK kinase (MEK) expressions
as well as their activation (phospho-forms) were inhibited by
hsp25 overexpression. Furthermore, when control vector
transfected cells were treated with PD98059, MEK inhibitor,
they became resistant to radiation, suggesting that inhibition
of ERK1/2 activities was essential for radioresistance in L929
cells. To confirm the relationship between ERK1/2 and hsp25-
mediated radioresistance, ERK1 or ERK2 cDNA was
transiently transfected into the hsp25 overexpressed cells
and their radioresistance was examined. HSP25-mediated
radioresistance was abolished by overexpression of ERK2,
but not by overexpression of ERK1. Alteration of cell cycle
distribution and cell cycle related protein expressions (cyclin
D, cyclin A and cdc2) by hsp25 overexpression were also
recovered by ERK2 cDNA transfection. Increase in Bcl-2
protein by hsp25 gene transfection was also reduced by
subsequent ERK2 cDNA-transfection. Taken together, these
results suggest that downregulation of ERK2 is essential for
the inhibition of radiation-induced cell death in HSP25
overexpressed cells.
Cell Death and Differentiation (2002) 9, 448 – 456. DOI: 10.1038/
sj/cdd/4400979
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Introduction
Cellular response to biological stresses is to produce heat
shock proteins (HSP). HSPs are divided into high-
molecular weight and low-molecular weight HSPs accord-
ing to their apparent molecular sizes. It is recognized that
low molecular weight HSPs such as HSP25, HSP27, and
aB-crystallin act as chaperones,1 and that HSP27 protein
participates in mediating physiological processes other than
the stress response, including cellular differentiation and
regulation of apoptosis.2 We earlier reported that over-
expression of hsp25 gene conferred radioresistance and
induced growth delay in L929 cells, and these alterations
were probably mediated by inhibiting expressions of cyclin
D1, A, and Cdc2, and increasing Bcl-2 expression,3 thus
leading us to the conclusion that the intracellular signal
transduction pathways associated with cell growth were
altered by HSP25 overexpression. This alteration might
have resulted in cell growth delay and radioresistance.
The mitogen-activated protein kinases (MAP kinases:
ERK1 and ERK2) are common intermediates in intracel-
lular signaling cascades involved in diverse cellular
functions, including growth and differentiation.4,5 The
regulatory network controlling MAP kinase in mammalian
cells is complex and consists of at least two pathways
which converge just upstream of MAP kinase at MAP
kinase kinase (MEK). One pathway involves the c-raf
proto-oncogene, while the other appears to be linked to
serpentine receptors via G protein and protein kinase C
(PKC).6 It is generally accepted that the activation of the
ERK cascade leads to cell proliferation.7,8 However, recent
investigations have attempted to clarify situations in a
number of cells where ERK mediates cell cycle arrest,9
antiproliferation,10 apoptotic11 and nonapoptotic death.12
Although it still remains unknown how the MAP kinase
pathway affects cellular survival or death in response to
ionizing radiation, our previous observations suggest that
the MAP kinase cascade is important for cellular response
to ionizing radiation. In the present paper, we observed
that the HSP25 overexpressed cells downregulated ERK1/
2 expression and that subsequent transfection of ERK2
cDNA, but not ERK1 cDNA, into the hsp25 gene
transfected cells eliminated HSP25 mediated-radioresis-
tance and cell growth delay.
Results
Overexpression of hsp25 induced radioresistance
To investigate relationship between HSP25 and radio-
resistance, we performed a clonogenic survival assay. As
shown in Figure 1A, hsp25-transfected cells (clone #8)
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showed an increased clonogenicity against ionizing
radiation-induced cytotoxicity. In order to appreciate the
mechanism of HSP25-induced radioresistance, we exam-
ined whether overexpression of hsp25 inhibited radiation-
induced apoptotic cell death, by assaying internucleoso-
mal fragments of apoptotic cells at 48 h after irradiation.
As seen in Figure 1B, g-rays induced an intense
fragmentation of DNA in vector control cells, while
overexpression of hsp25 (clones #6 and 8) drastically
inhibited this apoptotic death. Moreover, subsequent
transfection with antisense hsp25 cDNA abrogated
hsp25-induced radioresistance (Figure 1A,B). Furthermore,
HSP25-mediated altered expressions of cyclin D1, -A,
Cdc2, and Bcl-2 were also restored to the levels of
control vector cells after transfection with antisense hsp25
cDNA (Figure 1C).
HSP25 overexpression downregulated ERK1/2
expression
Since we observed earlier that overexpression of HSP25
induced cell growth delay,3 we examined the upstream
pathways of cell cycle regulation, particularly focusing on
the MAP kinase pathway. As shown in Figure 2A,B, both
ERK1 and 2 expressions and their kinase activities, with
MBP or PHAS-1 as a substrate were dramatically
decreased in the hsp25-transfected cells. When hsp25
cDNA was overexpressed into RIF (Radiation Induced
Fibrosarcoma) line, similar effects were obtained (Figure
1A). Transient transfection of hsp25 also decreased
ERK1/2 expression (Figure 2C). However, subsequent
transfection with antisense hsp25 cDNA recovered ERK1/2
expression to the level of control vector cells. Upstream
protein expressions of ERK1/2 and MEK1/2 were also
inhibited by hsp25 overexpression and subsequent
transfection with antisense hsp25 cDNA restored these
protein expressions. These data suggested that HSP25
overexpression downregulated ERK1/2 expression. In
addition, when treated with 4 Gy radiation, ERK1/2
activation occurred in the control cells, while this activation
was attenuated in the hsp25-transfected cells (Figure 2D).
Other MAP kinases such as p38 and JNK expressions
were not changed by hsp25 overexpression (data not
shown).
Figure 1 Overexpression of hsp25 induced radioresistance. (A) Surviving fraction of control vector-transfected cells (Control) and hsp25 gene-transfected cells
(HSP25#8) with or without subsequent hsp25 cDNA antisense (AS) transfection (HSP25#6/AS#1 and HSP25#8/AS#1) were obtained by colony-forming assay
after irradiation. (B) DNA fragmentation was measured by Hoechst 33258 staining 48 h after 4 Gy irradiation. Error bar indicates mean+S.D. from three
independent experiments. (C) Protein extracts were prepared, separated by SDS – PAGE, and analyzed by Western blot
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Half life of ERK1/2 Proteins was decreased by
HSP25 overexpression
To determine whether the HSP25 overexpression affected
de novo synthesis of ERK1/2 proteins, we assessed the
protein expression in the presence of 10 mg/ml of
cycloheximide (CHX), a potent inhibitor of protein synth-
esis. As seen in Figure 3A, the HSP25-overexpressed cells
decreased steady-state levels of ERK1/2 protein compared
with control cells. Northern blot analysis of the basal level
of ERK2 mRNA detected no difference (Figure 3B),
suggesting that ERK1/2 protein turnover was affected by
HSP25 overexpression.
Inhibition of ERK1/2 activity by PD98059 induced
radioresistance in L929 cells
To examine whether inhibition of ERK1/2 activity was
responsible for radioresistance, PD98059, a MEK inhibitor,
was treated. Irradiation activated ERK1/2 in the control vector
transfected cells, while it did not in the HSP25 transfectant
cells (Figure 4A). PD98059 induced radioresistance in both
cells, as evidenced by clonogenic survival assay or induction
of apoptosis, and the effect was greater in the control vector
cells (Figure 4B). These results suggested that inhibition of
ERK1/2 activities were essential for radioresistance in L929
cells.
Inhibition of ERK2 but not of ERK1 expression was
essential for the hsp25-mediated radioresistance
To test relationship between the level of ERK1/2 and
hsp25-mediated radioresistance, ERK1 or ERK2 cDNA
was transfected into the hsp25 overexpressed cells and
radioresistance was then examined. Using specific anti-
body for ERK1 or ERK2, increased level of ERK1 or
ERK2 proteins as well as their activation (phospho-ERK1/
2) were detected in the hsp25-transfected cells with no
alteration of HSP25 expression (Figure 5A). When
clonogenic survival and apoptosis assay were performed,
ERK2 but not ERK1 transfected cells exhibited the
inhibition of hsp25-mediated radioresistance (Figure
5B,C), indicating that ERK2 inhibition was essential for
hsp25-mediated radioresistance.
Figure 2 HSP25 overexpression downregulated ERK1/2 expression. (A) Protein extracts (60 mg) were prepared from control vector- (Control) and hsp25-
transfected (HSP25#6 and HSP25#8) cells with or without subsequent hsp25-antisense (AS) transfection (HSP25#6/AS#1 and HSP25#8/AS#2), separated by
SDS – PAGE, and analyzed by Western blotting. (B) ERK activity in cell lysates was measured by phosphorylation of phosphorylated heat and acid stable protein
(PHAS-1), a substrate for ERK-2, and myelin based protein (MBP), a substrate for ERK-1. (C) Transient transfection of control vector and hsp25 vector by
lipofection into L929 cells was performed. Protein extracts (60 mg) were prepared, separated by SDS – PAGE, and analyzed by Western blotting. (D) Protein
extracts (60 mg) were prepared from control vector- (Control) and hsp25-transfected (HSP25#8) cells which were harvested at 6 h after 4 Gy radiation, separated by
SDS – PAGE, and analyzed by Western blotting
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HSP25 mediated growth delay was abolished by
ERK2 transfection
Since HSP25 overexpression resulted in growth delay and
this growth delay was partially responsible for the HSP25-
mediated radioresistance, the growth curve was examined
after ERK-2 transfection. As shown in Figure 6A, growth delay
by HSP25 overexpression was restored to the level of control
cells after transfection with ERK-2 cDNA, however, no change
was detected when ERK-1 cDNA was transfected. To
examine whether the restoration of cell growth by ERK-2
cDNA transfection was due to alteration of cell cycle, cell cycle
was analyzed by flow cytometry. For this study, 400 mM
mimosine, known to reversibly block cells at the G1/S
boundary, was employed. Late G1 arrest was induced in
both control and hsp25-transfected cells by 20 h of drug
treatment. A 10 h after washing mimosine off, little more than
half of the HSP25 plus ERK-2 transfected cells had already
passed G2/M phase, but HSP25 alone and HSP25 plus ERK-
1 transfected cells did not yet pass (Figure 6B). These data
further indicated that the alteration of cell cycle by HSP25 was
restored to control cell level by subsequent transfection with
ERK-2 cDNA. Altered distribution of cell cycle by HSP25
overexpression was also restored by ERK-2 transfection
(Figure 6C): Increased G1 peak by HSP25 overexpression
was also diminished by ERK-2 cDNA transfection. A question
of whether the restoration of cell growth induced by ERK-2
cDNA transfection was due to restored expression of cell
cycle related proteins was analyzed by Western blot and the
result indicated that reduced basal levels of Cdc2, cyclin D1
and cyclin A proteins by HSP25 overexpression was restored
by ERK-2 cDNA transfection, but not ERK-1 cDNA transfec-
tion (Figure 6D). In addition, increased induction of Bcl-2 by
HSP25 overexpression was also reduced to the control level.
Discussion
It is generally accepted that the activation of the ERK
cascade leads to mitogenic effect.7,8 We earlier observed
that HSP25-mediated radioresistance was correlated with
growth inhibition and increased induction of Bcl-2 protein.3
Subsequent transfection with antisense hsp25 cDNA
abrogated hsp25-induced radioresistance. Simultaneously,
HSP25-mediated altered expressions of cyclin D1, -A,
Cdc2, and Bcl-2 were also restored to the levels of control
vector cells by transfection with antisense hsp25 cDNA
(Figure 1), suggesting that HSP25 induced radioresistance
through cell cycle regulation and Bcl-2 induction. We also
observed decreased expressions of ERK-1 and -2 along
with inactivation of ERK1/2 (decrease in the level of
phospho-ERK/2 proteins) in the hsp25-overexpressed cells
with no alteration of other MAP kinase expressions such as
Figure 3 Half life of ERK1/2 proteins was decreased by HSP25 overexpression. (A) Cells were treated with cycloheximide (CHX, 10 mg/ml) for 24 h, and protein
extracts (60 mg) were prepared at indicated times from control vector- (Control) and hsp25-transfected (HSP25#8) cells, separated by SDS – PAGE, and analyzed
by Western blotting. (B) Northern blotting analysis of ERK in control vector- (Control) and hsp25-transfected (HSP25#6 and HSP25#8) cells with or without
subsequent hsp25-antisense (AS) transfection (HSP25#6/AS#1)
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c-Jun NH2-terminal kinases (JNK, also called SAPK) and
the p38. Measurement of kinase activity of ERK-1 and -2
also confirmed our observations (Figure 2). In addition,
radiation-induced ERK1/2 activation was also inhibited by
HSP25 overexpression (Figure 4). These results strongly
indicated that the downregulation of ERK1/2, in particular
ERK2 gene expression might relate to the HSP25-mediated
radioresistance.
In an attempt to elucidate the mechanism of ERK1/2
protein regulation by HSP25 overexpression, we measured
steady-state levels of ERK1/2 proteins by treatment with
CHX. The steady-state levels of ERK1/2 proteins were
rapidly decreased in the HSP25 overexpressed cells,
indicating that HSP25 altered the half-life of ERK1/2 proteins
without altering mRNA levels of these genes (Figure 3). We
cannot offer any explanation on how HSP25 regulates the
half-life of ERK1/2 protein. There exists a possibility that
protein degradation system might have been altered by
HSP25 overexpression, because similar observation on the
half-life of cyclin D1 protein which was downregulated by
HSP25 overexpression (data not shown). The other possibi-
lity is a reactive oxygen species (ROS) system: Our
preliminary data revealed that HSP25-induced inhibition of
ERK1/2 expressions might have been mediated through
Ras-Raf signal transduction pathway, but not epidermal
growth factor receptor (EGFR) or protein kinase C (PKC)
pathways (unpublished data). NF-kB mediated increase in
manganese superoxide (MnSOD) expression, which is free
radical scavenging enzyme that defends cells from oxidant
stress by distorting superoxide anion (O2
.7) and reduces
ROS, was also observed in the HSP25 overexpressed cells
(data not shown). Therefore, it is quite possible that ROS in
the HSP25-overexpressed cells resulted in HSP25-mediated
ERK1/2 downregulation. Since Ras is critical for ERK1/2
activation by ROS,13,14 reduction of ROS level may be
responsible for the downregulation of ERK1/2. Recently, it
has been shown that ROS stimulate intracellular signal
events such as c-Src, Ras, and ERK1/2.15,16 and Guyton et
al.17 also showed that H2O2-stimulated ROS activated ERK2
in PC12 cells.
As shown in Figure 4, MEK inhibitor PD98059, which
consequently inhibited ERK1/2 activation, induced radio-
resistance in L929 cells. In particular, reduction of ERK2 level
and inhibition of its activation might have been responsible for
HSP25-mediated radioresistance (Figure 4). These observa-
tions were somewhat surprising, because ERK pathway is
known to be critical in the control of cellular growth and cell
survival responses to mitogenic signals in many different cell
systems, including those with tyrosine kinase, G protein-
coupled and cytokine receptors.18,19 Many studies support
the general view that activation of the ERK pathway delivers
a survival signal which counteracts proapoptotic effects
Figure 4 Inhibition of ERK1/2 activity by treatment with PD98059 induced radioresistance. Control vector-(Control) or hsp25-transfected (HSP25) cells were
pretreated with 50 mM PD98059 for 2 h, followed by irradiation with 4 Gy. (A) At indicated times, protein extracts (60 mg) were separated by SDS – PAGE, and
analyzed by Western blotting. (B) Relative viability was obtained by colony-forming assay. (C) DNA fragmentation was measured by Hoechst 33258 staining 48 h
after irradiation. Error bar indicates mean+S.D. from three independent experiments
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elicited by JNK and the p38 activation.20 However, require-
ment of ERK in mediating cisplatin-induced apoptosis of
human cervical carcinoma HeLa cells and ovarian cell
lines21,22 has also been demonstrated. Moreover, persistent
activation of ERK1/2 contributes to glutamate-induced
oxidative toxicity.23 In the present study, we also provided
evidence that ERK-2 cDNA transfection which affected cell
growth, Bcl-2 induction, and finally radioresistance induction
(Figures 5 and 6) abolished radiation-induced cell death in
the HSP25 overexpressing cells.
In this paper, we described possible involvement of
ERK2 in the development of radioresistance in the HSP25-
overexpressed L929 cells. Our proposed model shown in
Figure 7 might provide important insight in understanding
how HSP25 induces radioresistance. This model would
also provide a guideline to further in-depth study on the
mechanism of radioresistance induction by HSP25.
Materials and Methods
Cell culture
Murine L929 cells were cultured in Dulbecco’s minimal essential
medium (DMEM) (GIBCO, Gaithersburg, MD, USA) supplemented
with heat-inactivated 10% fetal bovine serum (FBS, GIBCO) and
antibiotics at 378C in a humidified incubator with a mixture of 95%
air and 5% CO2. L929 transformant clones were obtained from
stable transfection with phsp6 (containing the complete genomic
sequence for murine hsp25) and pBC vector (Stratagene, La
Jolla, CA, USA).3,24 Hsp25 transfectants were subsequently
transfected with plasmids containing antisense hsp25 cDNA which
was kindly provided by Dr Davidson,25 and stable transfectants
were selected with 6 mg/ml puromycin for approximately 2 weeks,
followed by continued growth in the presence of 4 mg/ml
puromycin. Clones with downregulated HSP25 protein detected
by Western blotting, were selected. Plasmid pcDNA3 with ERK1
or -226 was transiently transfected to HSP25 overexpressed cells
using lipofection.
Irradiation
Cells were exposed to g-rays with 137Cs g-ray source (Atomic Energy
of Canada, Ltd., Ontario, Canada) with dose rates of 3.81 Gy/min.
Colony-forming assay
Clonogenicity was compared, as described previously,3,27 by using a
colony-forming assay. Cells were seeded into 6 cm Petri dishes at
densities to produce approximately 500 colonies per dish in control,
and were incubated for 7 – 14 days. Colonies were fixed (75%
Figure 5 Subsequent transfection of ERK-2 but not ERK-1 cDNA to hsp25-transfected cells restored altered HSP25-mediated cell cycle. (A) Control vector-
(Control) and hsp25-transfected (HSP25) cells with or without subsequent transient transfection of vector control (HSP25#8/MFGpuro), ERK-1 (HSP25/ERK-1), or
ERK-2 (HSP25/ERK-2) were harvested. Protein extracts (60 mg) were separated by SDS – PAGE and analyzed by Western blotting. (B) Surviving fraction was
obtained by colony-forming assay after irradiation. (C) DNA fragmentation was measured by Hoechst 33258 staining 48 h after 4 Gy irradiation, as described in the
Materials and Methods. Error bar indicates mean+S.D. from three independent experiments
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methanol and 25% acetic acid) and stained with 0.4% trypan blue. The
number of colonies consisting of 50 or more cells was scored.
Detection of apoptosis
Cells were plated on glass slides and irradiated. After 24 or 48 h, cells
were fixed in 70% ethanol, washed with PBS, and were incubated with
1 mg/ml bisbenzimide trihydrochloride in PBS (Hoechst No. 33258) for
30 min at room temperature in the dark. Specimens were viewed by
fluorescence microscopy using Olympus BX-40 microscope. For each
determination, 200 cells at least were scored. Apoptosis was
characterized by chromatin condensation and fragmentation, giving
rise to ‘apoptotic bodies’.
Figure 6 HSP25-mediated growth delay was abolished by ERK-2 cDNA transfection. After transient transfection of ERK-1 or ERK-2 cDNA into hsp25-transfected
cells (HSP25#8/ERK1 or HSP25#8/ERK2), cell growth rate was measured at indicated times by counting cell number. (A) Relative growth rates of these cells were
compared. (B) Cells were preincubated for 20 h with 400 mM mimosine for synchronization, washed, and incubated for various times before cell cycle analysis. (C)
Comparison of cell cycle distribution in asynchronized cells after transient transfection of ERK-1 or ERK-2 cDNA into hsp25-transfected cells. (D) After transfection
of ERK-1 or ERK-2 cDNA to hsp25-transfected cells, protein extracts (60 mg) were separated by SDS – PAGE and analyzed by Western blotting
Figure 7 Proposed model of HSP25 mediated radioresistance. In the
proposed model, HSP25 downregulates ERK-2 expressions and affects cell
growth and Bcl-2 induction, resulting in induction of radioresistance
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G1-phase synchronization
Mimosine, a plant amino acid which reversibly blocks cells at the G1/S
boundary by inhibiting initiation of DNA replication and accumulating
p21WAF, was used to obtain populations with a greater degree of
synchrony in early S phase. Cells were plated 1 day prior to a 20 h
exposure to 400 mM mimosine. Following treatment, medium was
changed to drug-free medium, and cells were harvested thereafter at
various time intervals for cell cycle distribution studies.
Cell cycle analysis
For cell cycle analysis, cells were fixed in 80% ethanol at 48C for at
least 18 h. The fixed cells were then washed once with PBS-EDTA and
resuspended in 1 ml of PBS. After addition of 10 ml propidium iodide
(5 mg/ml) and 10 ml RNase (10 mg/ml), the samples were incubated
for 30 min at 378C and analyzed by FACScan flow cytometer (Becton
Dickinson, Frankin Lakes, NJ, USA).
Polyacrylamide gel electrophoresis and Western
blot
For polyacrylamide gel electrophoresis (PAGE) and Western blot, cells
were solubilized with lysis buffer [120 mM NaCl, 40 mM Tris (pH 8.0),
0.1% NP40], the samples were boiled for 5 min, and equal amount of
protein (40 mg/well) was analyzed on 10% SDS – PAGE. After
electrophoresis, proteins were transferred onto a nitrocellulose
membrane and processed for immunoblotting. Blots were incubated
with a 1 : 1000 dilution of antibodies against cell cycle-related proteins;
the mouse monoclonal anti-cyclin B1, anti-cdc2 antibody (Santa Cruz
Biotechnology, Inc., Santa Cruz, CA, USA), the rabbit polyclonal anti-
cdk2, -cdk4, -cyclin D1, -Bcl-2 (Santa Cruz Biotechnology), and -cyclin
E antibodies (Upstate Biotechnology, Inc., Lake Placid, NY, USA)
were used. For the detection of HSP25, blots were incubated with a
1 : 1000 dilution of goat polyclonal anti-HSP25 antibody (Santa Cruz
Biotechnology). Anti-phospho ERK1/2 or anti-ERK1/2 (New England
Biolabs Inc.), anti-phospho MEK-1/2 or anti-MEK1/2 (New England
Biolabs Inc.) antibodies were also used. Blots were further incubated
with horseradish peroxidase-conjugated secondary antibody diluted at
1 : 5000, and specific bands were visualized by chemiluminescence
(ECL, Amersham International). Autoradiographs were recorded onto
X-Omat AR films (Eastman Kodak Co.).
ERK kinase assay
ERK activities in cell lysates were measured by phosphorylation of
phosphorylated heat and acid stable protein (PHAS-1), a substrate for
ERK2,28 and myelin based protein (MBP), a substrate for ERK1.29
Briefly, subconfluent cell monolayers on 100 mm dishes were washed
twice with PBS, and scraped with 800 ml of lysis buffer [120 mM NaCl,
40 mM Tris (pH 8.0), 0.1% NP40]. ERK1 or ERK2 were immunopre-
cipitated by incubating 200 ml of lysate with 2 mg of antibody (Santa
Cruz Biotechnology, Inc.) for 2 h, and then by adding 20 ml of protein A
agarose (Santa Cruz Biotechnology). After an overnight incubation at
48C with end-over and washed three times with lysis buffer and once
with 250 mM HEPES (pH 7.4), 10 mM MgCl2, and 200 mM Na2VO4.
The ERK pellets were resuspended in lysis buffer containing 120 mg of
PHAS-1 or MBP substrate along with 3 – 5 mCi of [g32P] ATP in a final
volume of 180 ml. Kinase reaction took place for 30 min at room
temperature and were stopped by adding 46SDS – PAGE reducing
sample buffer and boiling for 10 min. ERK1-MBP or ERK2-PHAS-1
samples were resolved on SDS polyacrylamide gels, dried, and
autoradiographed.
Measurement of half-life of ERK1/2
To determine the half-life of ERK1/2 protein, cells were grown as
described above and treated with 10 mg/ml of cycloheximide (CHX) in
culture media for 24 h. After indicated times, proteins were extracted,
resolved by polyacrylamide gel electrophoresis and analyzed by
Western blotting as described earlier.
Acknowledgements
We thank KJ Kim for his excellent technical assistance. This work was
supported by Nuclear RD Program from the Ministry of Science and
Technology of Korea, and NIH CA 48000 of USA.
References
1. Craig BA, Weissman JS and Horwich AL (1994) Heat shock proteins and
molecular chaperones: mediators of protein conformation and turnover in the
cell. Cell 78: 365 – 372
2. Kindas-Mugge I and Trutinger F (1994) Increased expression of the Mr 27,000
heat shock protein (hsp27) in vitro differentiation normal human keratinocytes.
Cell. Growth Diff. 5: 777 – 781
3. Park SH, Cho HN, Lee SJ, Kim TH, Lee Y, Park YM, Lee YJ, Cho CK, Yoo SY and
Lee YS (2000) HSP25-induced radioresistance is associated with reduction of
apoptotic death: Involvement of Bcl-2 or cell cycle. Radiat. Res. 154: 421 – 428
4. Blumer KJ and Johnson GL (1994) Diversity in function and regulation of MAP
kinase pathways. Trends Biochem. Sci. 19: 236 – 240
5. Seger R and Krebs EG (1995) The MAPK signaling cascade. FASEB J. 9: 726 –
735
6. Ueda Y, Hirai S, Osada S, Suzuki A, Mizuno K and Ohno S (1996) Protein kinase
C activates the MEK-ERK pathway in a manner independent of Ras and
dependent on Raf. J. Biol. Chem. 271: 23512 – 23519
7. Marshall CJ (1998) Taking the Rap. Nature 392: 553 – 554
8. Grewall SS, York RD and Stork PJS (1999) Extracellular signal-regulated-kinase
signaling in neurons. Curr. Pion. Neurobiol. 9: 544 – 553
9. Pumiglia KM and Decker SJ (1998) Cell cycle arrest mediated by the MEK/
mitogen-activated protein kinase pathway. Proc. Natl. Acad. Sci. USA 94: 448 –
452
10. York RD, Yao H, Kollon T, Ellig CL, Eckert SP, McCleskey EW and Stork PJS
(1998) Rap1 mediates sustained MAP kinase activation induced by nerve growth
factor. Nature 392: 622 – 626
11. Mohr S, McCormick TS and Lapetina EG (1998) Macrophages resistant to
endogenously generated nitric oxide-mediated apoptosis are hypersensitive to
exogenously added nitric oxide donors: dichotomous apoptotic response
independent of caspase 3 inhibitor PD098059. Proc. Natl. Acad. Sci. USA 95:
5045 – 5050
12. Murray B, Alessandrini A, Cole AJ, Yee AG and Furshpan EJ (1998) Inhibition of
the p42/44 MAP kinase pathway protects hippocampal neurons in a cell-culture
model of seizure activity. Proc. Natl. Acad. Sci. USA 95: 11975 – 11980
13. Aikawa R, Komuro I, Yamasaki T, Zou T, Kudoh S, Tanaka M, Shiojima I, Hiroi Y
and Yazaki Y (1997) Norepinephrine induces the raf-1 kinase/mitogen-activated
protein kinase cascade through both alpha 1- and beta-adreno-receptors. J. Clin.
Invest. 100: 1813 – 1821
14. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, Sundaresan M, Finkel T
and Clermont-Goldschmidt PJ (1997) Mitogenic signaling mediated by oxidants
in Ras-transformed fibroblasts. Science 275: 1649 – 1652
15. Devary Y, Gottlieb RA, Smeal T and Karin M (1992) The mammalian ultraviolet
response is triggered by activation of Src tyrosine kinases. Cell 71: 1081 – 1091
16. Baas AS and Berk BC (1995) Differential activation of mitogen-activated protein
kinases by H2O2 and O2
7 in vascular smooth muscle cells. Circ. Res. 77: 29 – 36
17. Guyton KZ, Liu Y, Gorospe M, Xu Q and Holbrook NJ (1996) Age-related decline
inmitogen-activated protein kinaseactivity in epidermal growth factor-stimulated
rat hepatocytes. J. Biol. Chem. 272: 4138 – 4142
Cell Death and Differentiation
Downregulation of ERK2 and HSP25 cells
H Cho et al
455
18. Xia Z,DickensM, Raingaud J, Davis R and Greenberg M(1995)Opposing effects
of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 326 – 331
19. Robins MJ and Cobb MH (1997) Mitogen-activated protein kinase pathways.
Curr. Opin. Cell. Biol. 9: 180 – 186
20. Hayakawa J, Ohmichi M, Kurachi H, Ikegami H, Kimura A, Matsuoka T, Jikihara
H, Mercola D and Murata T (1999) Inhibition of extracellular signal-regulated
protein kinase or c-Jun N-terminal protein kinase cascade, differentially
activated by cisplatin, sensitizes human ovarian cancer cell line. J. Biol. Chem.
274: 31648 – 31654
21. Wang X, Martindale JL and Holbrook NJ (2000) Requirement for ERK activation
in cisplatin-induced apoptosis. J. Biol. Chem. 275: 39435 – 39443
22. Persons DL, Yazlovitskaya EM, Cui W and Pelling JC (1999) Cisplatin-induced
activation of mitogen-activated protein kinases in ovarian carcinoma cells:
inhibition of extracellular signal-regulated kinase activity increases sensitivity to
cisplatin. Clin. Cancer Res. 5: 1007 – 1014
23. Stanciu M, Wang Y, Kentor R, Burke N, Watkins S, Kress G, Reynolds I, Klann E,
Angiolieri MR, Johnson JW and DeFranco DB (2000) Persistent activation of
ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line
and primary cortical neuron cultures. J. Biol. Chem. 275: 12200 – 12206
24. Cho HN, Lee SJ, Park SH, Lee Y, Cho CK and Lee YS (2000) Overexpression of
heat shock protein 25 augments radiation-induced cell cycle arrest in murine
L929 cells. Intl. J. Radiat. Biol. 77: 225 – 233
25. Davidson SM and Morange M (2000) Hsp25 and the p28 MAPK pathway are
involved in differentiation of cardiomyocytes. Develop. Biol. 218: 146 – 160
26. Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, Morgenbesser SK,
DePinho RA, Panayotatos N, Cobb MH and Yancopoulos GD (1991) ERKs: A
family of protein-serine/threonine kinases that are activated and tyrosine
phosphorylated in response to insulin and NGF. Cell 65: 663 – 675
27. Park SH, Lee SJ, Chung HY, Cho CK, Yoo SY and Lee YS (2000) Inducible Heat
shock protein 70 (HSP70) is involved in radioadaptive response. Radiat. Res.
153: 318 – 326
28. Lin TA, Kong X, Haystead TA, Pause A, Belsham G, Sonerberg N and Lawrence
Jr JC (1994) PHAS-I as a link between mitogen-activated protein kinase and
translation initiation. Science 266: 653 – 656
29. Joseph TN, Yuan K, Yurong B, Esther Y, Katherine A and Christopher MP (1999)
Mitogenic signaling by ATP/P2Y purinergic receptors in astrocytes: Involvement
of a calcium-independent protein kinase C, extracellular signal-regulated protein
kinase pathway distinct from the phosphatidylinositol-specific phospholipase C/
calcium pathway. J. Neuroscience 19: 4211 – 4220
Cell Death and Differentiation
Downregulation of ERK2 and HSP25 cells
H Cho et al
456
